SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
About this item
Full title
Author / Creator
Publisher
United States: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
United States: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain-specific SARS-CoV-2 ancestral strain as a correlate for hig...
Alternative Titles
Full title
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b393d89de85d45698a93438f6f9f33c2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b393d89de85d45698a93438f6f9f33c2
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid3005.231739
